These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 24970872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1265-1273. PubMed ID: 28495863
    [Abstract] [Full Text] [Related]

  • 3. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G, Mattace Raso F, Sijbrands E, Seck MS, Maas R, Boger R, Witteman J, Rapisarda F, Malatino L, Mallamaci F, Zoccali C.
    Clin J Am Soc Nephrol; 2011 Jul 07; 6(7):1714-21. PubMed ID: 21642364
    [Abstract] [Full Text] [Related]

  • 4. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Lung; 2017 Dec 07; 195(6):717-727. PubMed ID: 28852826
    [Abstract] [Full Text] [Related]

  • 5. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.
    Am J Kidney Dis; 2015 Oct 07; 66(4):630-7. PubMed ID: 26002293
    [Abstract] [Full Text] [Related]

  • 6. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.
    Am J Nephrol; 2015 Oct 07; 42(1):25-34. PubMed ID: 26287973
    [Abstract] [Full Text] [Related]

  • 7. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
    Kim T, Rhee CM, Streja E, Soohoo M, Obi Y, Chou JA, Tortorici AR, Ravel VA, Kovesdy CP, Kalantar-Zadeh K.
    Am J Nephrol; 2017 Oct 07; 45(6):509-521. PubMed ID: 28528336
    [Abstract] [Full Text] [Related]

  • 8. Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status.
    Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner D, Bross R, Norris KC, Kopple JD, Kalantar-Zadeh K.
    Clin J Am Soc Nephrol; 2011 May 07; 6(5):1100-11. PubMed ID: 21527646
    [Abstract] [Full Text] [Related]

  • 9. Do income level and race influence survival in patients receiving hemodialysis?
    Eisenstein EL, Sun JL, Anstrom KJ, Stafford JA, Szczech LA, Muhlbaier LH, Mark DB.
    Am J Med; 2009 Feb 07; 122(2):170-80. PubMed ID: 19185093
    [Abstract] [Full Text] [Related]

  • 10. Prognostic efficacy of circulating asymmetric dimethylarginine in patients with peripheral arterial disease: A meta-analysis of prospective cohort studies.
    Chu R, Yu D, Chu J, Lin M, Yu H.
    Vascular; 2018 Jun 07; 26(3):322-330. PubMed ID: 28945167
    [Abstract] [Full Text] [Related]

  • 11. Serum β-trace protein and risk of mortality in incident hemodialysis patients.
    Shafi T, Parekh RS, Jaar BG, Plantinga LC, Oberai PC, Eckfeldt JH, Levey AS, Powe NR, Coresh J.
    Clin J Am Soc Nephrol; 2012 Sep 07; 7(9):1435-45. PubMed ID: 22745274
    [Abstract] [Full Text] [Related]

  • 12. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG.
    Am J Kidney Dis; 2008 Aug 07; 52(2):251-61. PubMed ID: 18468746
    [Abstract] [Full Text] [Related]

  • 13. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
    Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A.
    Am J Kidney Dis; 2006 Nov 07; 48(5):797-805. PubMed ID: 17059999
    [Abstract] [Full Text] [Related]

  • 14. Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients.
    Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple JD, Kalantar-Zadeh K.
    Am J Kidney Dis; 2011 Jun 07; 57(6):883-93. PubMed ID: 21239093
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C.
    J Hypertens; 2008 Sep 07; 26(9):1875-82. PubMed ID: 18698224
    [Abstract] [Full Text] [Related]

  • 16. Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients.
    Newsome BB, Kilpatrick RD, Liu J, Zaun D, Solid CA, Nieman K, St Peter WL.
    Am J Nephrol; 2013 Sep 07; 38(2):104-14. PubMed ID: 23899621
    [Abstract] [Full Text] [Related]

  • 17. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC.
    J Am Soc Nephrol; 1999 Mar 07; 10(3):594-600. PubMed ID: 10073610
    [Abstract] [Full Text] [Related]

  • 18. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C.
    Atherosclerosis; 2009 Dec 07; 207(2):541-5. PubMed ID: 19501358
    [Abstract] [Full Text] [Related]

  • 19. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.
    Clin Res Cardiol; 2013 Mar 07; 102(3):193-202. PubMed ID: 23073705
    [Abstract] [Full Text] [Related]

  • 20. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.
    Am J Kidney Dis; 2017 Jul 07; 70(1):48-58. PubMed ID: 28089476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.